Jaeseong Oh

1.1k total citations
84 papers, 723 citations indexed

About

Jaeseong Oh is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Jaeseong Oh has authored 84 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Pediatrics, Perinatology and Child Health and 14 papers in Oncology. Recurrent topics in Jaeseong Oh's work include Pharmacogenetics and Drug Metabolism (12 papers), Diabetes Treatment and Management (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Jaeseong Oh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Diabetes Treatment and Management (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Jaeseong Oh collaborates with scholars based in South Korea, United States and Puerto Rico. Jaeseong Oh's co-authors include Kyung‐Sang Yu, SeungHwan Lee, In‐Jin Jang, Jae‐Yong Chung, Joo‐Youn Cho, Richard A. Spritz, Seo Hyun Yoon, Sang Chun Ji, Se Joon Woo and Sang Jun Park and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Jaeseong Oh

71 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaeseong Oh South Korea	15	194	149	99	90	88	84	723
Ramesh Boinpally United States	19	219 1.1×	132 0.9×	204 2.1×	69 0.8×	87 1.0×	86	1.2k
Sameer Alharthi Saudi Arabia	16	273 1.4×	47 0.3×	104 1.1×	22 0.2×	41 0.5×	41	738
Katsuya Yamasaki Japan	15	163 0.8×	314 2.1×	54 0.5×	121 1.3×	151 1.7×	30	832
Kazushi Sakurai Japan	10	130 0.7×	157 1.1×	28 0.3×	64 0.7×	78 0.9×	18	520
H. Verhaegen Belgium	22	266 1.4×	153 1.0×	126 1.3×	26 0.3×	107 1.2×	85	1.5k
Wolfgang Erwa Austria	21	401 2.1×	102 0.7×	65 0.7×	21 0.2×	25 0.3×	37	1.1k
J.F. Horga Spain	17	181 0.9×	92 0.6×	63 0.6×	14 0.2×	85 1.0×	47	729
A. Grahnén Sweden	17	117 0.6×	65 0.4×	72 0.7×	38 0.4×	164 1.9×	40	756
Dandan Wang China	17	401 2.1×	114 0.8×	111 1.1×	5 0.1×	145 1.6×	64	1.2k
Hyewon Chung South Korea	16	128 0.7×	69 0.5×	64 0.6×	31 0.3×	50 0.6×	45	592

Countries citing papers authored by Jaeseong Oh

Since Specialization

Citations

This map shows the geographic impact of Jaeseong Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaeseong Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaeseong Oh more than expected).

Fields of papers citing papers by Jaeseong Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaeseong Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaeseong Oh. The network helps show where Jaeseong Oh may publish in the future.

Co-authorship network of co-authors of Jaeseong Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Jaeseong Oh. A scholar is included among the top collaborators of Jaeseong Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaeseong Oh. Jaeseong Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woo, Hyun, Tae‐Kyu Kwon, Sang Taek Heo, et al.. (2025). Prognostic nutritional index as an early predictor of mortality in patients with severe fever with thrombocytopenia syndrome: multicenter retrospective study in South Korea. BMC Infectious Diseases. 25(1). 274–274.

Choi, Youn Kyung, Sang-Chul Han, Jin Won Hyun, et al.. (2025). 5-Fluorouracil induces hair loss by inhibiting β-catenin signaling and angiogenesis. Chemico-Biological Interactions. 408. 111416–111416.

Lee, Ju‐Yeon, et al.. (2025). Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation. Biomarker Research. 13(1). 48–48.

Kim, Hoon, et al.. (2024). EFFECTIVENESS AND SAFETY OF RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (RHFSH) IN INFERTILE WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY (ART): A KOREAN NATIONWIDE RETROSPECTIVE COHORT STUDY. Fertility and Sterility. 122(4). e305–e305.

Jang, In‐Jin, et al.. (2024). Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects. Drug Design Development and Therapy. Volume 18. 2641–2652.

Li, Yingxin, et al.. (2024). Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose riliprubart, an anti-C1s humanized monoclonal antibody in East-Asian adults: results from a Phase 1, randomized, open-label trial. Expert Opinion on Investigational Drugs. 33(10). 1063–1074.

Chung, Woo Kyung, et al.. (2024). Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials. Translational and Clinical Pharmacology. 32(1). 30–30. 1 indexed citations

Kim, Yoonjin, et al.. (2024). A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine. npj Vaccines. 9(1). 140–140. 2 indexed citations

Park, Min Young, et al.. (2023). Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects. Clinical and Translational Science. 16(7). 1163–1176. 6 indexed citations

10.

Ji, Sang Chun, Jaeseong Oh, Hyojin Kim, et al.. (2023). Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects. Alimentary Pharmacology & Therapeutics. 57(7). 763–772. 12 indexed citations

11.

Jang, In‐Jin, et al.. (2023). Adaptive design clinical trials: current status by disease and trial phase in various perspectives. Translational and Clinical Pharmacology. 31(4). 202–202. 2 indexed citations

12.

Kim, Bo Rim, YoungRok Choi, Nam‐Joon Yi, et al.. (2023). Continuous versus intermittent infusion of human antithrombin III concentrate in the immediate postoperative period after liver transplantation. Clinical and Translational Science. 16(7). 1177–1185. 1 indexed citations

13.

Lee, Soyoung, Kyung Taek Hong, In‐Jin Jang, et al.. (2023). Semimechanistic pharmacokinetic–pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy. CPT Pharmacometrics & Systems Pharmacology. 12(9). 1319–1334. 1 indexed citations

14.

Chung, Woo Kyung, et al.. (2023). Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms. Clinical and Translational Science. 16(11). 2177–2188. 5 indexed citations

15.

Jang, Yoonhyuk, Han Sang Lee, Soon‐Tae Lee, et al.. (2023). Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling. Annals of Clinical and Translational Neurology. 11(2). 424–435. 1 indexed citations

16.

Lee, Soyoung, et al.. (2022). The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects. Clinical and Translational Science. 15(9). 2116–2126. 5 indexed citations

17.

Chung, Woo Kyung, et al.. (2022). Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and Translational Science. 16(3). 512–523. 4 indexed citations

18.

Lee, SeungHwan, Jaeseong Oh, Hyewon Chung, et al.. (2020). Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male Subjects. Clinical Therapeutics. 42(10). 1946–1954.e2. 3 indexed citations

19.

Yang, Kyung‐Moo, et al.. (2018). Characteristics of sauna deaths in Korea in relation to different blood alcohol concentrations. Forensic Science Medicine and Pathology. 14(3). 307–313. 1 indexed citations

20.

Oh, Jaeseong, SoJeong Yi, Namyi Gu, et al.. (2018). Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity. Genomics & Informatics. 16(3). 52–58. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact